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Lipid molecules are fundamental to cellular function and structure. Lipid metabolic events 
leading to these basic building blocks has been intensely studied, but are still not fully 
understood. Through five different studies on enzymes involved in activation and acylation 
of acyl groups done in three different model organisms we have uncovered novel data on 
lipid biosynthesis and utilization. 
  Saccharomyces cerevisiae contains two homologous glycerol-3-phosphate 
acyltransferases, GPT2 and SCT1, which catalyses the first step in the acyl-lipid assembly. 
Deletion or over expression of the corresponding genes has not only strong effects on the 
glycerol-3-phsophate activity but also on the total acyl content as well as on lipid and acyl 
composition. (Paper I) 
  The main form of storage lipids in seeds is Triacylglycerol. The TAZ1 from 
Saccharomyces cerevisiae, At104.1, and At104.2 from Arabidopsis thaliana are 
acyltransferase homologous genes that when overexpressed increase oil quantity in Yeast 
and Plants. (Patent I) 
  Wax esters and ethyl esters are unique constituents that have roles in energy storage and 
cell structure. In this work we show that microsomal preparations from Arabidopsis thaliana 
leaves efficiently acylate free fatty acids to long chain alcohols with no activation of the 
fatty acids to thioesters prior to acylation. We also show that in this enzymatic reaction long 
chain (C18–C24) unsaturated fatty alcohols and C18–C22 unsaturated fatty acids were 
preferred. (Paper II) 
  Long-chain acyl-CoA synthetases activate fatty acids and provide substrates for virtually 
every metabolic pathway that catabolizes FA or synthesizes complex lipids. In Mus 
musculus heart tissue we show that ACSL1 mRNA levels increase by 2.5 fold after birth, 
which correlates with the 14 fold increase in total ACSL activity at this time. In contrast, 
the levels of ACSL3, 4, and 6 mRNA were high in the embryonic heart, and decreased 
dramatically after birth suggesting that these isoforms may play a critical role during the 
development of the fetal heart. (Paper III) 
  Microsomes of Saccharomyces cerevisiae and developing Elm (Ulmus glabra) seeds 
contain a novel type of acyltransferase activity, a acyl-CoA dependent acylation of 
glycerophosphodiesters. Glycerophosphocholine was acylated by yeast microsomes with a 
Vmax of 8.7 nmol/min/mg protein and a Km of 2.5 mM. The GPCAT activity was sensitive 
to NEM, phenantroline and Zn
2+ ions. (Paper IV) 
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The human mind is powerful, we can imagine many worlds that don’t exist and it’s 
tempting to try and force reality to meet those views. I think you have to keep real 
things close and follow where nature takes you. If you set up experiments to test 
things you already know, then you can learn nothing, but if you let nature show 
you, and follow, then in that sense, serendipity might play a role. 
– Sir Paul Nurse Contents 
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A C S       A c y l - C o A   s y n t h e t a s e    
ACP      Acyl  carrier  protein   
ACSL      Long  chain  acyl-CoA  synthetase 
AGPAT     1-acyl-glycerol-3-phosphate  acyltransferase 
AT       Acetyl  transferase 
CPT-1    Carnitine  palmitoyltransferase-1   
DAG      Diacylglycerol 
DH       Dehydrogenase   
DHAPAT    Dihydroxyacetonephosphate  acyltransferase 
EnR     Enoyl  reductase   
ER       Endoplasmic  reticulum 
F A        F a t t y   a c i d  
FAS     Fatty  acid  synthase   
GPAT    Glycerol-3-phosphate  acyltransferase   
GPCAT     Glycerophosphocholine  acyltransferase 
GPEAT     Glycerophosphoethanolamine  acyltransferase 
KS       Ketoacyl  synthetase   
KR       Ketoacyl  reductase   
LCAD        Long chain acyl-CoA dehydrogenase  
LPA     Lysophosphatic  acid 
LPCAT     Lysophosphocholine  acyltransferase 
LPEAT     Lysophosphoethanolamine  acyltransferase 
MA       Malonyl  acetyl 
MAG      Monoacylglycerol 
MAM      Mitochondrial  associated  membrane 
MCAD     Medium  chain  acyl-CoA  dehydrogenase 
mMDH     Mitochondrial  malate  dehydrogenase   
MPT      Malonyl  palmitoyl-transacylase   
ORF      Open  reading  frame 
PA         Phosphatidic  acid   
PC       Phosphatidylcholine 
PDAT    Phospholipid:diacylglycerol acyltransferase  
PE         Phosphatidylethanolamine 
PPAR      Peroxisome  proliferator-activated receptor 
P S        P h o s p h a t i d y l s e r i n e  
SCAD        Short chain acyl-CoA dehydrogenase  
TAG        Triacylglycerol 
T E        T h i o e s t e r a s e    
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Introduction 
 
The metabolic steps leading to the synthesis of lipids are very complex. Today 
there are still many unanswered questions about phospholipid biosynthesis. 
Understanding these processes can have large impacts on the developments of 
biotechnological advances in industry, medicine, consumer products and nutrition. 
Today these advances are becoming more important with the ever-growing 
population of the world and consumption of natural products. As well as increased 
consumption of natural products, there is an increasing epidemic of obesity. This 
epidemic is especially clear in children in the United States of America. Healthier 
oils have become an important component in good nutrition and of major concern 
to the general public. Enhancement of oil seed quality and quantity is growing in 
importance every year. In this thesis I address; lipids, model organisms used to 
study lipid biosynthesis, glycerol-3-phosphate acyltransferase, tafazzin, long chain 
acyl CoA synthetase, and novel wax ester and ethyl ester synthetases. 
   
Why do we study lipids? 
Lipids are components essential to all organisms. They are utilized in many cellular 
functions such as membrane formation (fig. 1), defense mechanisms and as an 
energy source for cellular processes. To date, there have been thousands of studies  
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Figure 1. The fluid mosaic model:  This schematic shows a representation of the fluid 
mosaic model of the plasma membrane based on theories by Singer and Nicholson in 1972 
(Singer & Nicolson, 1972). The plasma membrane is comprised of phospholipids as 
represented here with their hydrophilic head groups and hydrophobic tails. The large 
masses here represent integral proteins imbedded or attached to the membrane. 
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conducted over the last century on the production and metabolic processes of 
lipids. Understanding lipid formation is an important step towards directed 
bioengineering. The potential for large breakthroughs in medicine and agriculture 
are unlimited with the increased understanding of lipid forming processes. While 
many of the enzymatic steps leading to glycerolipids have been characterized and 
the genes that influence them have been cloned, there are still many missing pieces 
in the puzzle. There is vast potential for using knowledge of these cellular 
functions to improve existing products and techniques. 
 
The different classes of lipids 
In the past, lipids have been described as biological substances that are generally 
hydrophobic in nature. William Christie has submitted the following definition: 
lipids are fatty acids and their derivatives, and substances related biosynthetically 
functionally to these compounds (Christie, 2003). This is close to the traditional 
definition from Bloor in the 1920’s, where he classified lipids into three groups: 
simple lipoids (fats and waxes), compound lipoids (glycolipids and phospholipids), 
and derived lipoids (fatty acids, alcohols and sterols) (Bloor, 1920). Christie’s 
definition allows us to include cholesterol, plant sterols and possibly bile acids and 
tocopherols as lipids. It is accepted now that lipids can be separated into two major 
classes: simple and complex lipids. Simple lipids as defined by Christie are lipids 
that yield at most two primary products per mole and complex lipids yield three or 
more primary products per mole (Christie, 2003). Simple lipids include 
triacylglycerol, diacylglycerol, monoacylglycerols, fatty acyls, sterols, sterol esters, 
waxes, and acylglycerols. Complex lipids include glycerophospholipids, 
glycosphingolipids, and glycoglycerolipids. Fahy et al., 2005 has proposed that 
these two main classes should be broken further into eight classes: fatty acyls, 
glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, 
saccharolipids, and polyketides (Fahy et al., 2005). In this thesis, I will discuss 
three of these classes: fatty acyls, glycerolipids, and glycerophospholipids. 
 
Fatty Acyls  
Fatty acyls is a definition which includes diverse simple structures such as fatty 
acids (FAs), fatty alcohols and simple acyl lipid structures (Table 1; Fig. 2). They 
are constituents of neutral lipids, polar lipids, as side chains of some co-enzymes, 
secondary metabolites, as covalent attachments to distinct eukaryotic proteins, as 
parts of eukaryotic second-messenger molecules, energy storage, in the integrity 
and dynamic of biological membranes, as well as being a main controlling factor in 
cellular metabolism. There are five fatty acids that are normally referred to as 
common that are usually found in membranes and are the main components of 
vegetable oils. These are palmitic acid, stearic acid, oleic acid, linoleic acid and 
linolenic acid (Table 1). The enzyme complex that produce fatty acids is the Fatty 
acid synthase (FAS). The mechanism of de novo FA synthesis is similar in all 
biological systems. However, there is considerable variation in the organization of 
the different FAS complexes/polypeptides and subcellular localization. In plants, 
de novo FA synthesis takes place in the plastids, while in other eukaryotes it takes 
place in the cytosol. The main building blocks of FAS are ac(et)yltransferase,  11 
malonyl/acetyl- or malonyl/palmitoyl-transacylase, ketoacyl synthase (KAS), 
ketoacyl reductase, dehydratase, enoyl reductase, acyl carrier protein (ACP), and 
thioesterase (Schweizer & Hofmann, 2004). Saturated acyl chains are formed by 
the condensation of two carbon units from malonyl-ACP to acetyl/acyl chains with 
palmitoyl- and stearoyl-ACP as the predominant products (Voelker & Kinney, 
2001). In this process the growing FAs are attached through an ester bond to ACP. 
Each two carbon elongation cycle includes four reactions: condensation of 
malonyl-ACP and ac(et)yl-ACP, reduction of 3-ketoacyl-ACP, dehydration of 3-
hydroxyacyl-ACP, and finaly reduction of trans-∆
2-enoyl-ACP. The final product 
of these four steps is a fully reduced acyl chain extended by two carbons. The 
condensing enzymes are very specific for chain length. KAS III condenses C2-C4, 
KAS I condenses C4-C16 and KASII condenses C16-C18, (Clough et al., 1992; 
Shimakata & Stumpf, 1984). In plants the elongated FA are then cleaved from 
ACP by thioesterases exported out of the plastids and activated to acyl-CoA 
(Schnurr, Shockey & Browse, 2004). The acyl-CoAs are then utilized by various 
metabolic pathways such as membrane synthesis, seed storage lipid synthesis as 
well as cuticular lipid synthesis (Aharoni et al., 2004). 
 
Figure 2. Three examples of fatty acyl structures utilized in this thesis, Structures were 
drawn with ACD/ChemSketch. 
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Table 1. Fatty acids utilized in this thesis. The shorthand 
designation marked with a star (*) are not naturally produced in 
plants. 
Systematic name  Trivial name  Shorthand 
designation 
Butanoic  butyric 4:0 
Hexanoic  caproic 6:0 
Octanoic  caprylic 8:0 
Decanoic  capric 10:0 
Dodecanoic  lauric 12:0 
Tetradecanoic  myristic 14:0 
Hexadecanoic  palmitic 16:0 
∆ 9-hexadecanoic  palmitoleic  16:1(ω-7) 
Octadecanoic  stearic 18:0 
∆ 9-octadecenoic  oleic 18:1 
∆ 9,12-octadecadienoic  linoleic  18:2(ω-6) 
∆ 9,12,15-octadecatrienoic  α-linolenic  18:3(ω-3) 
∆ 6,9,12-octadecatrienoic   γ-linolenic  18:3(ω-6) * 
Eicosanoic  arachidic 20:0 
Eicosenoic  gadoleic 20:1 
∆ 8,11,14-eicosatrienoic  dihomo- γ-linolenic  20:3(ω-6) 
∆ 5,8,11,14-eicosatetraenoic  arachidonic  20:4(ω-6) * 
∆ 5,8,11,14,17-eicosapentanoic  EPA 20:5  * 
docosanoic  behenic 22:0 
docosenoic  erucic 22:1 
∆ 7,10,13,16,19-docasapentaenoic  clupanodonic (DPA)  22:5 
∆ 4,7,10,13,16,19-docosahexaenoic  cervonic (DHA)  22:6 * 
tetracosanoic  lignoceric 24:0 
tetracosenoic  nervonic 24:1 
hexacosanoic  cerotic 26:0 
hexacosenoic   26:1 
 
 
Glycerolipids  
This class of lipids encompasses simple lipids that contain glycerol. These 
molecules have important roles as metabolic fuels with the most common 
molecular structure being the triacylglycerol (TAG, Fig. 3), in membrane 
composition and as signaling molecules. 2-monoacylglycerols are intermediates or 
end products of the hydrolysis of TAG or diacylglycerol (DAG, Fig. 3) during 
digestion (Christie, 2003). While typically a small percentage in total lipid content, 
some monoacylglycerols (MAGs, Fig. 3) have been found to be integral to certain 
membranes and to have specific physiological functions. MAGs also serve 
importance in industry as food surfactants. Derivatives from MAGs are also 
utilized in many cosmetic products. Some examples of this are 2-
arachidonoylglycerol, which is found to be approximately half of the total MAG 
content in nervous tissue; 2-sciadonoylglycerol, containing the rare unsaturated 
fatty acid, sciandonic acid, that has cannabimimetic activity and is found in seeds 
and leaves of all conifers; 1-butyrylglycerol, which appears to be a key regulatory 
molecule in angiogenesis; and monoacylglycerols, which are a major constituent of  13 
cutin polymers (Dobson et al., 1990; Graca et al., 2002; Kondo et al., 1998; 
Nakane et al., 2000). 
 
  DAGs (Fig. 3) are important intermediates in TAG synthesis. DAGs are also a 
precursor to phosphatidylethanolamine (PE) and phosphatidylcholine (PC) 
synthesis. They are important signaling molecules, which can activate cellular 
mechanisms directly with direct protein interaction or indirectly with fatty acid 
release. The formation of DAG comes from the lipid biosynthesis pathway trough 
the dephosphorylation of phosphatidic acid (PA) by phosphatidic phosphatase or 
from degradation of phospholipids through phospholipases. In the food industry, 
DAGs are becoming key components of cooking sprays. Oils rich in DAGs have 
recently become an important tool for fighting obesity (Rudkowska et al., 2005).  
 
  Triacylglycerols are important molecules in energy metabolism. They are the 
main component of all important commercial plant, animal fat and oil products. 
TAG is formed by the acylation of DAG at the sn-3 position with Acyl-CoA. TAG 
molecules can also be formed by an acyl-CoA independent formation called 
phospholipid:diacylglycerol acyltransferase PDAT (Dahlqvist et al., 2000; Stahl et 
al., 2004). TAG molecules accumulate to form lipid bodies either in the outer 
membrane of the ER or on the surface of the ER. 
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Figure 3. Three examples of glycerolipids utilized in this thesis, Structures were drawn 
with ACD/ChemSketch. 
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Glycerophospholipids 
The major glycerophospholipid group is the phospholipids, which are amphiphatic 
molecules that are biologically important for all organisms. They are utilized by the 
cells in hundreds of cellular functions such as membrane structure, permeability, 
and specialized defense mechanisms and as a source of energy for cellular 
processes. Phospholipids have a polar head group at the sn-3 position on their 
glycerol backbone (Fig. 4). Understanding phospholipid biosynthesis can allow us 
to utilize these cellular functions for designing druges as well as for manipulating 
storage lipid deposition in seeds. In S. cerevisiae, the phospholipi classes that make 
up the membrane composition are PC, phosphatidylserine (PS), PE, and 
phosphatidylinositol  (Paltauf, 1992). Phospholipid composition in the membranes 
can vary drastically with environmental changes, and substrate availability.  
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Figure 4. Diagram of a phospholipid structure, structures were drawn with 
ACD/ChemSketch. 
 
  Glycerol-3-phosphate is the main precursor in phospholipid biosynthesis in the 
Kennedy pathway (Kennedy, 1961). Lysophosphatidic acid (LPA) can be produced  15 
by two conjoining sections of the Kennedy pathway. The first and the main source 
of LPA occur from the acylation of glycerol-3-phosphate at the sn-1 position. The 
second way LPA  is produced starts with the acylation of dihydroxyacetone 
phosphate (DHAP) at the sn-1 position to yield 1-acyl-DHAP that is further 
reduced in a NADPH dependent reaction to form LPA (Athenstaedt & Daum, 
2000; Sandager et al., 2002; Schlossman & Bell, 1978). In vertebrates, LPA is 
found to affect cell proliferation, cell growth, calcium regulation, and apoptosis 
(Fueller et al., 2003; Ye et al., 2002). In mammals, there are four reported G-
protein-coupled receptors that are activated by LPA (Anliker & Chun, 2004). LPA 
is also an important intermediate in TAG biosynthesis. 
 
  PA is an important intermediate on the way to TAG synthesis in the Kennedy 
pathway. It is also accepted that PA is an important second messenger in both 
animals and plants and activate G-proteins and protein kinases (McPhail et al., 
1999; Munnik, 2001; Testerink et al., 2004). PA is formed by the acylation of LPA 
at the sn-2 position (Fig. 5). The two enzymatic steps glycerol-3-phosphate 
acyltransferase (GPAT) and lysophosphatic acid acyltransferase (LPAAT or 
AGPAT) that catalyze the biosynthesis of LPA and PA, respectively, both utilize 
acyl-CoA as the acyl donor substrate. 
 
  There are many reasons for manipulating phospholipid biosynthesis. Diseases 
caused by problems in producing phospholipids afflict many people. In medical 
research and the pharmaceutical industry, drugs and medical techniques can be 
designed based on data from basic research. Increasing oil specificity and quantity 
in plants can also increase our ability to create sustainable resources for industrial 
products and personal consumption. Through manipulation of phospholipid 
biosynthesis, we may also be able to create “healthier” foods that can allow us to 
have longer, more productive lives. Basic scientific research on the steps that affect 
TAG accumulation is very important for improving many aspects of life. 
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Figure 5. Scheme showing the acylation of LPA to PA at the sn-2 position, structures were 
drawn with ACD/ChemSketch. 
 
Different Model Systems Used in Studying Lipid 
Biosynthesis 
Better understanding of the natural world not only enhances all of us as 
human beings, but can also be harnessed for the better good, leading to 
improved health and quality of life. – Sir Paul Nurse 
 
Why do we use model organisms to study lipid biosynthesis? 
In the last century, model organisms have become a prominent way to examine 
inheritance and genetics. In recent years, they have been used to look at metabolic 
events and cellular systems. Model organisms have become a very important tool 
because of the ease and speed in which new discoveries can be made with them. In 
recent years, model organisms have become a very prominent tool due to the large 
increase in gene sequence information and bioinformatics tools. To date, there 
there is a rapidly growing number of organisms with complete or nearly complete 
genome sequences. They include the Bakers Yeast (Saccharomyces cerevisiae) 
(Goffeau et al., 1996), Schizosaccharomyces pombe (Wood et al., 2002), fruit fly 
(Drosophila melanogaster) (Adams et al., 2000), malaria parasite (Plasmodium 
falciparum) (Gardner et al., 2002; Holt et al., 2002), ciliated protozoan 
(Tetrahymena pyriformis) (Tetrahymena Genome Database), Candida albicans 
(Candida Genome Database), Escherichia coli, mustard cress weed (Arabidopsis 
thaliana) (2000), Domestic Rice (Orza sativa) (Goff et al., 2002; Yu et al., 2002), 
puffer fish (Fugu rebripes) (Aparicio et al., 2002), mouse (Mus musculus) 
(Waterston et al., 2002), rat (Rattus norvegicus), and human (Homo sapiens) 
(Lander et al., 2001; Venter et al., 2001).  
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  All of these model organisms have become important tools in analyzing the 
function of various genes and gene families. The proteins that are encoded by our 
genome are often very complex and possess multiple functional domains. Protein 
modifications such as phosphorylation, glycosylation and subcellular localization 
often have a large determination on protein function (Barr, 2003). Understanding 
genetic function is a very complex story. The use of model organisms allows us to 
look at these complex mechanisms with greater speed. In the past, before Genome 
Sequencing, model organisms were used to study classic molecular genetics, 
development and physiology (Barr, 2003). Today, good model organisms must be 
able to be examined with a genomic approach. This means the ability to see 
changes in phenotype, metabolism, and gene products due to gene manipulation. 
An ideal model organism must also be able to be used to determine dominance, 
complementation, and recombination. The organism’s usefulness in these areas is 
largely dependent on the information and tools available concerning its sequence. 
As well as being able to meet the criteria above, an ideal model organism must also 
meet the traditional standards of small size, quick generation time, ease of 
maintenance and low cost. In this thesis, we explored the use of three model 
organisms to analyze lipid biosynthesis: Saccharomyces cerevisiae, Arabidopsis 
thaliana,  and  Mus musculus. All these organisms fit both the modern and 
traditional criteria for being good model organisms. 
 
Saccharomyces cerevisiae   
Saccharomyces cerevisiae is one of the most powerful model organisms to date. 
It is the most cited model organism with over 50,000 references listed in PubMed. 
In S. cerevisiae, 6,419 open reading frames have been identified. S. cerevisiae has 
several unique properties that give it advantages over more complex eukaryotic 
organisms. It is able to grow on defined media. This allows control over its 
chemical and physical environments. The life cycle of S. cerevisiae is well suited 
for experimental design and allows for rapid accumulation of data. S. cerevisiae is 
not a pathogen, which allows for ease in uses and handling for experiments. 
Beyond being a great model organism, S. cerevisiae has been a first in many high 
throughput genomic approaches. It was the first eukaryote to be transformed by 
plasmids, the first to have targeted gene disruption through homologous 
recombination, and it was the first to be fully sequenced (Beggs, 1978; Goffeau, et 
al., 1996; Rothstein, 1983). With its unique characteristics, we are able to start 
identifying several protein functions with several tools such as gene specific 
knockouts and/or overexpressions, two-hybrid and modified two-hybrid screens, 
subcellular localization with GFP, co-immuno precipitation, gene and mRNA 
expression patterns, and enzymatic activity/function analysis. 
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Arabidopsis thaliana 
Arabidopsis thaliana is a small weedy flowering plant from the mustard family, 
Brassicaceae, which has been considered the foremost model organism in plants. 
A. thaliana is a weed and has no economical importance in agriculture, but has vast 
significance in biotechnology. A. thaliana has become an established model 
organism for a variety of reasons. The foremost of these is its relatively small 
genome size, which contains approximately 27,855 genes that was mostly 
sequenced and published in the Nature Journal in 2000, and was annotated for the 
fifth time in July of 2004 by the TIGR database (2000; Haas et al., 2005). Besides 
having a fully sequenced genome there are a variety of bioinformatics tools 
available for A. thaliana. It has further more a small seed size, fast life cycle of 
approximately 6 weeks from germination to mature seed, ability to grow in a small 
space, efficient and quick transformation protocols, and commercial availability of 
a large number of mutant lines. A. thaliana has been used as a model organism to 
study a number of physiological processes such as disease resistance, pathogen 
host interactions, plant hormone responses, and environmental responses, thereby 
increasing our understanding of plant utilization in industry. 
 
Mus Musculus  
Mus musculus has become a very important model organism, helping us 
understand human diseases and enzyme function. Mice and humans diverged 
approximately 75 million years ago (Madsen et al., 2001; Murphy et al., 2001; 
Waterston, et al., 2002). When comparing the mouse and human genome, 40% of 
the nucleotides are identical and 80% of the genes have one to one corresponding 
counterparts (Emes et al., 2003). An almost complete mouse genome was 
published in 2002 by the mouse genome sequencing consortium, and is comprised 
of approximately 30,000 protein coding genes (Waterston, et al., 2002). Mice have 
become an important tool for understanding human physiology. This is not only 
because of their fairly closely related genomes, but because a large number of 
human genes do not have homologues in invertebrates. It has also been important 
to look at tissue specific genes when trying to understand human physiology. This 
cannot be done using invertebrate eukaryotes. Mice is a great model organism 
because it allow us to look at important enzymatic and physiological changes in 
controlled environments through knockouts and mutant strains as well as 
overexpression of genes through viral replication. 
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Background to studies included in the thesis 
 Glycerol-3-Phosphate Acyltransferase (GPAT).  
 
 
Figure 6. Scheme of glycerophospholipid biosynthesis (Kennedy Pathway) in yeast 
Saccharomyces cerevisciae. Abbreviations not listed previously acyl.Co-A (A-CoA), 
inositol (IN).   
 
  The first step in lipid biosynthesis is the acylation of glycerol- 3-phosphate at the 
sn-1 position to LPA, which is catalyzed by the enzyme glycerol-3-phosphate 
acyltransferase (GPAT). In eukaryotic cells, multiple isoforms of GPAT are 
present and they are localized in different intracellular compartments (Dircks & 
Sul, 1997; Murata & Tasaka, 1997). This initial step in acyl lipid biosynthesis is 
predicted to be important for the regulation of production of membrane 
glycerolipids and TAG. Manipulation of TAG synthesis is an important goal for 
the future of biotechnology. TAG is an important storage compound and is a major 
reserve source of energy for the plant. The production of TAG can also act as a 
sink for DAG and acyl-CoA, preventing toxic concentrations to accumulate in the 
cell (Alvarez et al., 2001; Olukoshi & Packter, 1994). TAG from plants in the form 
of vegetable oils and fats are major commodities in agriculture. These products 
have a global annual production of 100 million tons. For these reasons, GPAT is an 
obvious candidate to manipulate, for use in plant biotechnology, to increase the oil 
yield and quality in oil crops. Aberrations in GPAT activities are also highly 
important in many human diseases which manifest due to dysfunctional 
phospholipid production (Hajra & Bishop, 1982). 
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  The major site of complex lipid assembly in the cell is in the ER. A prokaryotic 
GPAT gene was cloned two decades ago in Escherichia coli and encodes an 
integral membrane protein with a molecular weight of 83 kDa (Green, Merrill & 
Bell, 1981). In 2001, two ER localized GPAT genes were cloned in S. cerevisiae, 
GPT2 and SCT1 (Zheng & Zou, 2001). Zheng and Zou showed that GPT2 and 
SCT1 affect GPAT, and dihydroxyacetone phosphate acyltransferase (DHAPAT) 
activities in both wild type and overexpression mutants of S. cerevisiae (Zheng & 
Zou, 2001). These yeast GPATs share conserved amino acids of the acyltransferase 
motif. In 2001, there were no obvious GPAT homologues to these genes in plants 
and animals. In 2003, a family of ER localized GPATs was identified in A. 
thaliana (Zheng et al., 2003). 
 
  While many questions about GPAT in acyl lipid biosynthesis have recently been 
answered, there is still a need to characterize this part of the phospholipid pathway. 
GPAT exhibits the lowest specific activity of enzymes in the glycerol lipid pathway 
which suggests that this step is rate-limiting in acyl lipid biosynthesis (Bell & 
Coleman, 1980; Coleman et al., 1978). It is a widely accepted view that there are 
two ER GPAT isoforms in S. cerevisiae, SCT1 and GPT2. Studies from other 
organisms suggest that more than two GPAT isoforms may exist in S. cerevisiae. 
These additional isoforms are predicted to encode GPAT in different organelles 
other than ER. It is also apparent that there are separate lipid pools in the cell 
(Rustow & Kunze, 1985). This would suggest there are different GPAT isoforms, 
which have specific functions for varying conditions, and have different organelle 
distribution. 
 
  In eukaryotic cells, multiple isoforms of the enzyme GPAT are present and 
localized to different intracellular compartments (Dircks & Sul, 1997; Murata & 
Tasaka, 1997). A soluble plant plastidial and a murine mitochondrial localized 
GPAT have been cloned (Ishizaki et al., 1988; Yet et al., 1993). The plant 
plastidial and the animal mitochondrial GPAT carry out specialized functions. In 
plants, plastidial GPAT is the part of the prokaryotic pathway responsible for 
acylating glycrol-3-phosphate utilizing acyl-ACP as the acyl donor for plastidial 
lipid biosynthesis (Thelen & Ohlrogge, 2002). The animal mitochondrial GPAT 
has a specific role in TAG biosynthesis and is located in the outer mitochondrial 
membrane (Gonzalez-Baro, Granger & Coleman, 2001; Igal et al., 2001). The 
specific function and compartmentalization in plants and animals indicates that this 
may also be the case in S. cerevisiae. 
 
  Even though it has been shown that the two yeast GPAT enzymes, GPT2 and 
SCT1, complement each other, there are some differences between properties and 
effects of the two enzymes. First, the SCT1 gene was cloned as a multicopy 
suppressor of a ctr1 ise double mutant yeast strain (Zaremberg & McMaster, 
2002). The ctr1 ise double mutant is dependent on choline when grown on a high 
inositol medium due to a mutated phosphatidylethanolamine methyltransferase. It 
also has the choline transporter (ctr1) mutated, leading to an increased Km value 
for choline uptake (Thai et al., 1997). GPT2 was not cloned as a suppressor in this 
screen, indicating a difference in function between the two yeast GPAT enzymes. 
Furthermore, the reduction in GPAT activity in crude extract of a GPT2 deleted  21 
yeast strain was about 90%, whereas deletion of SCT1 led to only a 30% reduction 
(Zheng & Zou, 2001). In 2001, Zhen and Zou determined that there was a 
difference in acyl specificity. GPT2 and SCT1 show an ability to efficiently utilize 
four substrates; 16:0-CoA, 16:1-CoA, 18:0-CoA and 18:1-CoA, although GPT2 
has a reduced efficiency in utilizing 18:0-CoA, while SCT1 has distinct preference 
for 16:0-CoA, and 16:1-CoA (Zheng & Zou, 2001). In 2001, Zheng et al. 
established that in the knock-out mutant strains gpt2∆ and sct1∆, there was a 
decrease in PA production.  
 
These results showed that gpt2∆ increased both PC and PS levels, and decreased in 
PE, and that the sct1∆ strain had a different composition with a little increase in PE 
levels and a slight increase in PS production compared to the gpt2∆ strain (Zheng 
& Zou, 2001). They also found that gpt2∆ did not have an overall effect FA 
composition except for a decrease in 16:1 content in PE that was compensated by 
an increase in the 16:0 and 18:1 PE content. The sct1∆ deletion impacted fatty acid 
composition in PC, PI, PS, and PE with a general decrease in 16:0 balanced by a 
proportional increase in other fatty acids primarily 18:0 (Zheng & Zou, 2001). It 
has been conclusively shown that a double knockout of GPT2 and SCT1 is a 
synthetically lethal strain (Zaremberg & McMaster, 2002; Zheng & Zou, 2001). 
 
  Zaremberg and McMaster (2002) further characterized these genes by feeding 
yeast cells with 
14C-labeled acetate and showed that the gpt2∆ strain had a quite 
strong increase in incorporation into TAG as compared to the wt strain and that 
deleting the SCT1 gene had the opposite effect. They further more showed that 
when the gpt2∆ strain was labeled with [
14C]choline, there was a strong increase in 
radiolabled glycerophosphocholine (GPC) incorporation. In the sct1∆ strain, there 
was a decrease in radio-labeled PC and also a decrease in radio-labeled GPC 
incorporation. 
 
  Comprehension of how genes influence FA composition can help us understand 
how to manipulate these genes to create products with very specific acyl 
specificities. This information is important for the future of biotechnology and in 
the creation of genetically modified oils for specific uses. These changes in 
composition may also be important to understand what is happening in many 
human genetic disorders when fatty acid compositions are abnormal. 
Understanding the role of GPATs in these processes gives us important tools to 
further our understanding of lipid production. The papers cited above give further 
evidence to the extreme complexities of lipid biosynthesis. 
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Tafazzin in Homo sapiens, Saccharomyces cerevisiae, and 
Arabidopsis thaliana. 
 
Acyl-CoA
MLCL
CL PE, PC
MLCL
Acyl-CoA
CoA or 
Adenine nucleotide
PLA2
MCLT
Mitochondrial
pool
Endoplasmic reticulum
pool
PLA2
MLCLAT1
ALCAT1
Acyl-CoA
MLCL
CL PE, PC
MLCL
Acyl-CoA
CoA or 
Adenine nucleotide
PLA2
MCLT
Mitochondrial
pool
Endoplasmic reticulum
pool
PLA2
MLCLAT1
ALCAT1
   
Figure 7. Suggested model for cardiolipin remodeling. ALCAT1-Acyl-CoA cardiolipin 
acyltransferase, MLCLAT1-monolysocardiolipin acyltransferase, MCLT-mitochondrial 
cardiolipin transacylase, PLA2 - phospholipase A2 (Hauff & Hatch, 2006; Schlame et al., 
2002). 
 
  Lipids are important storage molecules in seeds of many angiosperms. The main 
form of lipid storage in seeds is TAG. Plants readily utilize the TAG energy source 
during germination. In plants, TAG is usually comprised of palmitate, stearate, 
oleate, linoleate and linolenate (Voelker & Kinney, 2001). Many products in 
industry and food production come from the processing of lipids from oilseeds. 
Some of these include cooking oils, biodiesel, industrial lubricants, cosmetics, 
medicines, plasticizers, surfactants, etc. As well as having multiple uses in 
industrial applications, seed oils are of major importance to human dietary 
consumption. With ever-growing concerns about cardiac health, healthier oils have 
become an important component in good nutrition. Enhancement of oil seed 
quality and quantity is growing in importance. 
 
 TAZ1 is homologous to a region called Xq28 in humans, which is believed to be 
responsible for Barth Syndrome (Bolhuis et al., 1991). Barth syndrome is an X-
linked cardioskeletal myopathy and neutropenia with abnormal mitochondria and 
increased levels of organic acids in the urine which was first characterized in 1983 
(Barth et al., 1983). Barth syndrome is a type of Zellweger syndrome 
(leukodystrophy), which often causes fatality in childhood due to cardiac failure or 
sepsis, even in times of apparent good health (Barth, et al., 1983; Wilson et al., 
1986). The cardiomyopathy associated with Barth syndrome often leads to  23 
weakness and fatigue (Barth, et al., 1983). In 1996, several mutations in this region 
were reported and named G4.5, or Tafazzin (Bione et al., 1996). The mutations 
described in this region are splice-site, missense, nonsense, and frameshift (Bione, 
et al., 1996; Cantlay et al., 1999; D'Adamo et al., 1997; Johnston et al., 1997). 
Alterations in the coding region of the gene are linked with Barth Syndrome. There 
are also lipid abnormalities associated with Barth syndrome including decreased 
cholesterol, docosahexaenoic acid, arachidonic acid (Barth et al., 2004), and 
cardiolipin.  
 
The Tafazzin gene has some homology to known acyltransferases that are active 
in phospholipid biosynthesis (Neuwald, 1997). Recently, it has been suggested that 
TAZ1 in yeast is involved in the metabolism of cardiolipin, especially in the fatty 
acid remodeling of this mitochondria specific lipid molecule (Schlame, et al., 
2002; Valianpour et al., 2003; Vreken et al., 2000). Cardiolipin is an essential 
component in mammalian cells. In the mammalian heart, CL makes up 15-20% of 
the phospholipid phosphorus content (Hatch, 2004). This involvement in 
cardiolipin remodeling was suggested because cultured skin fibroblasts from 
patients with Barth syndrome had a decrease in cardiolipin (CL) levels and a 
reduction in linoleic acid incorporation (Schlame, et al., 2002; Valianpour, et al., 
2003; Vreken, et al., 2000). Further studies in 2002 showed that cells from Barth 
syndrome patients lack tetralinoleoyl-CL (Schlame, et al., 2002). It has been shown 
that Barth syndrome causes aberrant cardiolipin accumulation (Schlame, et al., 
2002; Valianpour, et al., 2003; Vreken, et al., 2000). CL accumulates on the outer 
membrane of the mitochondrial membrane, mitochondria associated membrane 
(MAM) fraction (Ma et al., 1999; Rusinol et al., 1994),  as well as the inner 
mitochondrial spaces (Koshkin & Greenberg, 2002; Schlame, Rua & Greenberg, 
2000). Earlier studies on Barth syndrome have even shown there is aberrant 
formation of the mitochondria, where there is a condensation of the inner 
mitochondrial space (Neustein et al., 1979). Bradner et al. (2005), conclusively 
proved that TAZ1 is localized in the outer mitochondrial membrane in yeast. 
Tafazzin and TAZ1 have been proposed to be transacylases transferring acyl 
groups from PC to cardiolipin (Xu et al., 2003). Further evidence of this is that in a 
taz1∆ yeast strain, there was an increase in accumulation of monolysocardiolipin. 
Also, tafazzin mutations cause changes in cardiolipin acyl composition as well as 
cardiolipin levels (Gu et al., 2004; Vaz et al., 2003). 
 
  Cardiolipin synthesis in S. cerevisiae is similar to that in higher eukaryotes. Due 
to this, yeast TAZ1 has become an important tool for looking at diseases such as 
Barth syndrome. In eukaryotes, cardiolipin is formed by two glycerol-linked 
moieties; the four acyl chains are typically mono- and diunsaturated fatty acids 
(Brandner et al., 2005). There have been two genes identified in de novo 
cardiolipin biosynthesis in yeast. They are PGS1, which encodes 
phosphatidylglycerol phosphate (PGP) synthase (Chang et al., 1998a). PGP is then 
dephosphorylated by PGP phosphatase to PG. Then CRD1 catalyzes the 
phosphatidyl transfer from CDP-DAG to PG to form CL (Chang et al., 1998b; 
Jiang, Rizavi & Greenberg, 1997; Tuller et al., 1998).  
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A..thaliana At104.1 and At104.2 enzymes have 31.6 and 26.3% identical amino 
acids, respectively, to  S. cerevisiae. In plant cells, lyso-PC acyltransferase is 
located in the plastidial envelope and mitochondrial membranes (Bessoule, Testet 
& Cassagne, 1995; Testet et al., 1996). These enzymes are supposed to be the key 
enzymes that import PC from the ER into cellular organelles. In plants, Nebaurer et 
al. (2004) proposed that this import involves the release of lyso-PC from 
endomembranes in the transfer of these molecules to the mitochondria and 
chloroplasts for their subsequent acylation into PC. In mammals, newly formed 
cardiolipin is then rapidly remodeled to generate CL enriched with linoleic acid 
(Hatch, 2004). It has been proposed that there are two functions of cardiolipin; the 
first is that it is important for membrane stabilization (Hatch, 2004), secondly, that 
it is important for protein function by direct protein interactions (Palsdottir & 
Hunte, 2004). 
 
  Our knowledge of Tafazzin has been limited at best. After two decades of 
intensive research, we still do not understand the true function of this gene. We do 
understand that Tafazzin is required for proper lipid regulation. There are many 
unresolved questions associated with Barth syndrome. To date, we do not 
understand what the true cause of Barth syndrome is or how the functions of TAZ1 
influence normal lipid synthesis. Further knowledge in this area is required for us 
to understand the protein encoded by this gene and to create action plans to 
maintain healthy lipid production in humans. 
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Wax Ester and Ethyl Ester Synthesis  
Figure 8.. Scheme of wax ester and ethyl ester synthesis in plants. 
 
    Epicuticular and intracuticular waxes form hydrophobic barriers that are 
utilized as a major defense mechanism in plants (Broun et al., 2004). This waxy 
layer protects plants from environmental changes, insects, and non-stomatal water 
depletion. Waxes also have a role in protection against bacterial and fungal 
pathogens (Kolattukudy, 1987).  
 
  In addition to being involved in plant protection, processed waxes play an 
important role in plant developmental metabolism. This role includes the 
prevention of post-genital organ fusion and pollen-pistil interactions (Aharoni, et 
al., 2004). Important structural functions of wax esters include regulation of 
buoyancy and or sound transmission, energy storage, and cuticle permeability, 
which is hypothesized to influence cell to cell communication by attenuating the 
passage of signal molecules (Cheng & Russell, 2004; Kalscheuer et al., 2006; 
Sieber et al., 2000). They are a main constituent of mammalian sebum and 
meibum, and the epicuticular and intracuticular layer in plants (Broun, et al., 2004; 
Cheng & Russell, 2004). As well as affecting these processes, Pruitt et al. 
suggested that cuticle permeability influenced cell to cell communication by 
attenuating the passage of signal molecules (Sieber, et al., 2000).  
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  Cuticular wax is mainly composed of long chain aliphatic compounds derived 
from very long chain fatty acids (Kunst & Samuels, 2003). The wax composition in 
plants varies between species but is also dependent on environmental factors.  
 
 In  A. thaliana leaves, wax esters make up 0.2% of the epicuticular lipid classes 
(Jenks et al., 1995). In some plants, such as jojoba, wax esters are one of the main 
components in the cuticular layer as well as the seeds (Benzioni, 1989). Wax esters 
are produced by the estrification of fatty acids, to fatty alcohols. The only known 
enzymes involved in this reaction have been fatty acyl CoA: fatty alcohol 
acyltransferases (wax synthase, WS) (Kolattukudy, 1967; Kolattukudy & Rogers, 
1978; Metz et al., 2000). 
 
  Little is known about the function of ethyl esters. We know that they play key 
roles in fermentation in microorganisms and in flavor compounds in food and 
alcoholic beverages. Ethyl esters are also a component in many pharmaceutical 
products (Mason & Dufour, 2000; Saerens et al., 2006). In mammals, they may 
also play a role in organ injury due to acute alcohol intoxication (Diczfalusy et al., 
2001). As well as being important constituents in fermentation and food flavors, 
ethyl esters are beginning to be recognized as important biomarkers in diseases 
such as chronic alcohol abuse (Kaphalia et al., 2004). Fatty acid ethyl esters 
(FAEE) are formed by two enzymatic processes; esterification of alcohols and 
carboxylic acids catalyzed by FAEE synthetases/carboxylases or alcoholysis from 
alcohols and acylglycerols or alcohols and acyl-CoA’s by acyl-CoA:ethanol O-
acyltransferases (AEAT) (Laposata, 1998). In yeast, two main medium-chain fatty 
acid ethyl ester synthetases have been identified, EHT1 and EEB1 (Saerens, et al., 
2006). However, the results from Saerens et al. indicate that S. cerevisiae may have 
one or more additional enzymes involved in ethyl ester synthesis (Saerens, et al., 
2006). To date, enzymes involved in FAEE synthase in A. thaliana have not been 
characterized. 
 
  The precursors for wax ester and ethyl ester production in plants are synthesized 
by a combination of plastidial or cytosolic de novo fatty acid synthesis and 
cytosolic elongation. In this process, palmitic, stearic, and oleic acid are produced 
by soluble enzymes in the FAS complex in the plastid (Ohlrogge & Browse, 1995). 
The growing acyl chain is attached to acyl carrier protein (ACP). These products 
go through four reactions: a condensation of malonyl-ACP to acetyl-ACP, a 
reduction of β–ketoacyl-ACP, dehydration of β–ketoacyl-ACP, and lastly, the 
reduction of trans-∆
2-enoyl-ACP. The final product of these four steps is a fully 
reduced acyl chain extended by two carbons.  
 
  The condensing enzymes in this step are very specific for chain length. KAS III 
condenses (C2-C24), KAS I condenses (C4-C16) and KASII condenses (C16-
C18), (Clough, et al., 1992; Shimakata & Stumpf, 1984). The acyl-acp’s are then 
cleaved from the acyl carrier protein by thioesterases and exported to the 
endoplasmic reticulum in the form of acyl-CoA’s (Schnurr, Shockey & Browse, 
2004). The acyl CoA is then utilized in various metabolic pathways such as the 
synthesis of membrane, seed storage and cuticular lipids (Aharoni, et al., 2004). 
Plant waxes are mainly composed of very long-chain fatty acids (VLCFA). These  27 
VLCFA are derived by microsomal enzymes that elongate the FA exported from 
the plastid by two carbons at a time by a similar biochemical reaction as in the de 
novo fatty acid synthesis. Four basic reactions are repeated until the desired chain 
length is acquired; condensation, reduction, dehydration, and a second reduction 
(von Wettstein-Knowles, 1986). FA elongation then takes place through the action 
of the condensing enzyme, Fatty acid elongation enzyme (FAE) (Von Wettstein-
Knowles 1982). It has been previously described that after FAE, there are two 
principle wax biosynthetic pathways, the acyl reduction pathway and the 
decarbonylation pathway. The decarbonylation pathway starts with the production 
of aldehydes from VLCFA precursors by fatty acyl-CoA reductase. The next step 
is a decarbonylation of aldehydes by the aldyhyde decarbonylase to make alkanes. 
The alkanes can be used to form secondary alcohols and ketones. The step that we 
are most interested in is the acyl reduction pathway, which in plants is catalyzed by 
the fatty acid reductase (FAR). In two steps this reaction converts the fatty acid to 
the aldehyde and then reduces it to produce primary alcohols. Both the reduced 
aldehydes and the primary alcohols then used to make wax esters by the acylation 
from acyl-CoA (Kunst & Samuels, 2003). In this thesis, we describe a third branch 
in the wax biosynthetic pathway. This third division in wax production is a 
reduction pathway that utilizes reduced aldehydes or primary alcohols to 
transacylate neutral lipids to form wax esters without involvement of acyl-CoA 
(This Work). 
 
 In  A. thaliana, there are 22 known Cer mutants that cause defects in wax 
synthesis. Cer 1-10 mutants have a very glossy phenotype and Cer 11-22 are glossy 
to a lesser degree (Shimakata & Stumpf, 1984). The identification of these mutants 
has given us important tools to study the production of wax. By studying these 
mutations, it has been determined that most of these mutations do not cause an 
accumulation of metabolic intermediates due to blocks in the pathway. Instead, 
there is a flux in precursors into alternate branches of the pathway causing complex 
changes in wax formation (Rhee et al., 1998; von Wettstein-Knowles, 1979). The 
complexity of this pathway would lead us to conclude that there are many 
alternatives in the production of waxes. There are many enzymatic steps for which 
there is no obvious gene yet identified and several mutants for which no function is 
ascribed (Rashotte et al., 2004). It is most likely these various pathways are 
activated under different conditions based on needs of the plants, availability, and 
the accumulation of certain products. 
 
  Understanding how waxes are formed in plants can have significant importance 
for plant biotechnology. By understanding these complex mechanisms we may be 
able to create plants with enhanced resistance to insect and environmental damage 
and to modified wax compositions. Modification of wax compositions is highly 
advantageous for the production of industrial and consumer wax products from 
plant sources. 
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Heart Long-Chain Acyl-CoA Synthetase. 
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Firgure 9. Scheme of products produced and processes influenced by synthesis of acyl 
CoA. triacsin C and troglitazone (TGZ) are inhibiters. 
 
  Long chain acyl-CoA synthetases (ACSLs) are an integral part of nearly all 
biosynthetic pathways that lead to production of fatty acid derived molecules. 
ACSLs catalyze the conversion of long chain fatty acids to long chain fatty acyl-
CoAs (Kornberg & Pricer, 1953). The formation of acyl-CoAs occurs in a two-step 
process. The first step converts free fatty acid to an acyl-AMP intermediate 
(adenylate) through the pyrophosphorolysis of ATP. In the second step, the 
adenylate is then coupled with the thio group of CoA releasing AMP and  
acyl-CoA as products (Groot, Scholte & Hulsmann, 1976). There are five 
characterized isoforms of ACSLs in humans and rodents. ACSL 1, 6, and 5 have 
over 60% amino acid identity (Oikawa et al., 1998). ACSL 3 and 4 have 68% 
identity with each other and approximately 30 percent homology with ACSL1 
(Kang et al., 1997). These ACSLs differ in cellular and organelle localization, 
enzyme kinetics, regulation, and substrate preferences (Mashek et al., 2004).  
 
  In addition to having varying substrate preferences, the acyl-CoA synthetase 
products can be utilized in many metabolic processes such as β-oxidation, fatty 
acid retroconversion, glycerolipid biosynthesis, phospholipid reacylation, 
desaturation, elongation, cholesterol ester, and wax ester formation. They can also 
serve as signaling molecules (Coleman, Lewin & Muoio, 2000; Coleman et al., 
2002; Faergeman & Knudsen, 1997; Prentki & Corkey, 1996; Schnurr et al., 2002; 
Stoveken et al., 2005). In addition to these integral differences, there are also 
diverse quantities of ACSL isoforms in other organisms. In Arabidopsis thaliana,  29 
there are nine LACS (ACSLs) (Schnurr, et al., 2002). In S. cerevisiae, there are 
four characterized FAAs (ACSLs) with a possibility of a fifth, FAA5, inferred by 
the lack of lethality with the quadruple knock: ∆faa1, ∆faa2, ∆faa3, and ∆faa4 
(Knoll et al., 1995). All of the ACS super family share similar composition, with a 
putative AMP binding and fatty acid binding sites. Previous studies that have 
characterized the mammalian ACS family have shown integral differences in how 
acyl-CoAs are channeled. The most compelling evidence is varied response of the 
ACSL isoforms to different inhibitors. 
 
  Triacsin C is a fungal-derived competitive inhibitor. In 1997, Igal et al. showed 
that in human fibroblasts, 5 μM of Triacsin C inhibits de novo synthesis of 
triacylglycerol by 99% and phospholipids by 83% (Igal, Wang & Coleman, 1997). 
In the same paper, they also proposed that there are different pools for ACSL 
products. It was hypothesized that Triacsin sensitive ACSLs can only be used to 
acylate cholesterol, glycerol-3-phosphate, lysophosphatic acid and diacylglycerol. 
Triacsin resistant ACSL products can only be used by lysophospholipid 
acyltransferases,  β-oxidation and ceramide N-acyltransferase (Igal & Coleman, 
1996; Muoio et al., 2000). In 2001, Kim et al. showed that ACSL1 and ACSL4 in 
rats were inhibited in a dose dependent manner with an IC 50 of 4-6 μM (Kim, 
Lewin & Coleman, 2001). 
 
  Another important inhibitor family is the thiazolidinediones. Thiazolidinediones 
exert many of their effects through a mechanism that involves activation of the 
gamma isoform of the peroxisome proliferator-activated receptor (PPAR gamma), 
a nuclear receptor. Thiazolidinediones induce activation of PPAR gamma, which 
alters the transcription of several genes that are considered key regulators of energy 
homeostasis, insulin sensitivity and inflammation (Berger & Moller, 2002; 
Chinetti, Fruchart & Staels, 2000; Jiang, Ting & Seed, 1998; Picard & Auwerx, 
2002). Troglitazone in particular, blocks incorporation of oleate into 
triacylglycerol and ketone body production but does not inhibit incorporation of 
oleate into phospholipids (Fulgencio et al., 1996; Muoio, et al., 2000). 50 µM of 
Troglitazone inhibits ACSL4 activity by 45% in the mitochondria associated 
membrane (MAM) fraction (Lewin et al., 2001). Further evidence of specific 
channeling of ACSL products is their varied substrate specificity between the 
different ACSL isoforms. 
 
  There are many ontological changes that occur between the developmental stages 
of Mus musculus heart. The most pronounced of these changes is the metabolic 
switch from use of glucose and lactate in the fetal heart to fatty acids and amino 
acids used by the adult heart (Fisher, Heymann & Rudolph, 1980; Wakefield et al., 
2005; Werner et al., 1983). 
 
  The fetal rat heart primarily consists of slow-twitch oxidative voluntary muscles. 
After birth, these muscles mature to mainly be composed of fast twitch glycolytic 
fiber (Close, 1964; Dubowitz, 1963). After birth, there is a significant up-
regulation of many genes in the mouse and rat heart. These genes include carnitine 
palmitoyltransferase-1, mitochondrial malate dehydrogenase, short chain acyl-CoA 
dehydrogenase, medium chain acyl-CoA dehydrogenase, long chain acyl-CoA   30
dehydrogenase, and peroxisome proliferator-activated response elements α, and δ, 
(Brown et al., 1995; Carroll et al., 1989; Disch et al., 1996; Kelly et al., 1989; 
Nagao, Parimoo & Tanaka, 1993; Steinmetz et al., 2005). Many of these genes are 
in the acyl-CoA dehydrogenase family, which is involved in fatty acid oxidation 
(Carroll, et al., 1989). 
 
  It is of interest that genes involved in mitochondrial fatty acid oxidation are up-
regulated as well. In 1976, Foster and Bailey showed an up-regulation of several 
mitochondrial fatty oxidation genes after birth which included acyl-CoA synthetase 
(Foster & Bailey, 1976). The elevated expresion of mitochondrial fatty acid 
oxidation genes could be due to the increase in mitochondria content in the heart in 
response to changes in ventricular loading and increased demands in cardiac output 
(Attardi & Schatz, 1988; Mayor & Cuezva, 1985). There are also changes at 
postnatal day eighteen as the mouse pups begin to eat more mouse chow and 
depend less on their mother’s milk. Smith et al. published that mouse milk consists 
primarily of medium chain fatty acids, mainly capric acid, lauric acid, myristic 
acid, palmitic acid, and oleic acid (Smith, Watts & Dils, 1968). Further evidence of 
the importance of glucose for the fetal heart is shown by a 10-fold greater 
sensitivity to insulin compared to the adult (Clark, 1971; Clark, 1973). In rats, 
during the last four days before birth, both plasma glucogen and insulin 
concentration rise several fold with the preservation of a ratio of more than ten 
with respect to the adult. After birth, there is a large fall in insulin and a steep rise 
in plasma glucogen, creating a drop in the same ratio (Girard et al., 1985). In the 
fetal rat heart, there is also a sharp increase in the adrenaline stimulation of 
adenylate cyclase right before birth (Clark et al., 1980). Before birth, in rats, cyclic 
AMP is immediately involved in the contraction process and in the mobilization of 
glycogen in the heart. There is also a sharp increase in the ability of adrenalin to 
stimulate adenylate cyclase in the fetal rat heart (Clark, et al., 1980). In the rat 
early newborn period, retention of protein is high and agents such as cyclic AMP 
that normally inhibit protein synthesis do not do so (Klaipongpan, Bloxham & 
Akhtar, 1977). In rats, these changes may be preparing the heart for perinatal 
mobilization of cardiac glycogen. 
 
  Fetuses also have high oxygen binding capacity with associated leftward shift of 
the hemoglobin dissociation curve. The higher oxygen binding capacity enhances 
oxygen affinity on the blood (Bartels, 1964). This allows the fetus and neonates to 
be less sensitive to hypoxia (Singer, 1999). Some other major physiological 
differences are that the fetal heart has a reduced number and less active 
mitochondria, little fatty acid or amino acid oxidation, and poorly developed 
tubular systems with low CA
2+, Na
+, K
+, -ATPase and relatively high rates of 
glycolysis and lactate production in the aerobic state (Jones & Rolph, 1981). 
 
  Besides the major physiological differences that occur before and just after birth, 
many other changes occur during developmental stages of Mus musculus. There is 
a switching-off of thermoregulation by the fetus related to a metabolic reduction. 
This phenomenon can even occur in extremely young neonates. This allows the 
fetus to create a near-induced hypothermia in case of exposure to cold (Singer, 
1999). By postnatal day five in mice, fuzz starts to appear on mouse bodies and by  31 
postnatal day eleven, they are fully furred. There are also changes in diet that 
include, for example, a major change when teeth erupt at day ten and again after 
weaning at day twenty-one. There is a postnatal rise in total cholesterol (Roberts, 
Huff & Carroll, 1979). This may be due to dietary changes, such as a change from 
mother’s milk being the primary food source to a chow diet. Brain immaturity 
plays an additional role in reducing metabolic needs (Thurston & McDougal, 
1969). 
 
  It is important for us to understand the functional roles of each ACSL isoform. 
Understanding this can give us important tools to help us create treatment 
strategies for many diseases such has diabetes and obesity. With the alarming 
increase in these disorders in the last few years, it is imperative for us to increase 
our understanding of the causes and possible treatment plans for them. 
 
Phosphatidylcholine synthesis in Saccharomyces cerevisiae  
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Figure 10. Scheme of Novel GPCAT Pathway in S. cerevisiae, structures were drawn with 
ACD/ChemSketch. 
 
 
  Phosphatidylcholine is the major phospholipid in eukaryotic cellular membranes. 
PC formation is highly regulated and plays critical roles in cellular biosynthesis, 
degradation, and distribution in cells (McMaster, 2004). To date, the knowledge on 
the biosynthesis of PC in yeast involves two pathways; the CDP-choline or 
Kennedy pathway and the PE methylation pathway. The CDP-choline pathway 
contains the genes: CKI1, PCT1 and CPT1, and the PE metylation pathway the   32
gens: CHO2 and OPI3 (Dowd, Bier & Patton-Vogt, 2001; Fernandez-Murray & 
McMaster, 2005).  
Minimal levels of PE are essential for cellular growth (Birner et al., 2001). In WT 
yeast GPC is somewhat generated extracellularly by the action of three 
phospholipase B enzymes: PLB1, 2 and 3 (Merkel et al., 2005; Patton, Pessoa-
Brandao & Henry, 1995) but mainly intracellularly through deacylation of PC 
molecules derived from the CDP-choline pathway by the NTE1 hydrolase.  (Dowd, 
Bier & Patton-Vogt, 2001; Fernandez-Murray & McMaster, 2005; Zaccheo et al., 
2004). 
 
  In yeast outer mitochondrial membranes, PC and PI are equally distributed 
across both sides of the membrane while PE is localized in the intermembrane 
space (Sperka-Gottlieb et al., 1988). GPC is generated extracellularly by the action 
of three phospholipase B enzymes: PLB1, 2 and 3 (Merkel, et al., 2005; Patton, 
Pessoa-Brandao & Henry, 1995). PC molecules derived from the CDP-choline 
pathway can be deacylated from NTE1 esterase, which utilizes the product 
lysophosphatidylcholine (LPC) to form glycerophosphocholine (GPC) (Dowd, Bier 
& Patton-Vogt, 2001; Fernandez-Murray & McMaster, 2005; Zaccheo, et al., 
2004). 
 
  The regulation and synthesis of PC is integral to proper function of metabolic 
function. This is shown by the induction of many diseases and physiological 
distress when there are problems with the production or regulation of PC. There 
are several mutant strains with defects in PC biosynthesis and these mutants have 
the tendency to generate respiratory-deficient petites (Griac, Swede & Henry, 
1996). When there are deficiencies in PC regulation, many pathological events 
such as apoptosis (Anthony, Zhao & Brindle, 1999) and cancer occur (Aboagye & 
Bhujwalla, 1999). In Saccharomyces cerevisiae, GPC accumulation increases in 
response to high temperatures, choline in the media, and osmotic stress (Dowd, 
Bier & Patton-Vogt, 2001; Kiewietdejonge et al., 2006). Altered GPC 
accumulation has been seen in a number of disorders in the human brain such as 
Alzheimer’s disease (Walter et al, 2004) and schizophrenia (Shirayama et al., 
2004).  
 
In this thesis, we describe novel acyltransferase activities that influence PC 
regulation. These reactions are catalyzed by glycerophosphocholine acyltransferase 
(GPCAT) and glycerophosphoethanolamine acyltransferase (GPEAT) activities. 
The combined reaction of known acyltransferases LPCAT with GPCAT and 
LPEAT and GPEAT create a novel recycling pathway of glycerophosphodiesters 
into phospholipids. GPCAT and GPEAT are more efficient and energy saving than 
previously described mechanisms by Patton-Voigt et al. in 2006 (Patton-Vogt, 
2006).  33 
Aims of this thesis 
  
“Most things are simple when you understand them.”  – Ulf Ståhl 
 
Overall: The overall aim of this thesis was to study different fatty acid acylation 
and CoA-activation activities regarding biochemical activity properties, cellular 
functions, localization and regulation. Three different model organisms:                
S. cereviseae, A. thaliana and M. musculus, were used in these studies on basic 
lipid metabolism.  
 
Paper I: To study the effects on lipid content and composition as well as on fatty 
acid composition in yeast induced by altering the expression levels of either of the 
two glycerol-3-phosphate acyltransferase genes, GPT2 and SCT1 
 
Patent 1: To characterize the effects on the lipid accumulation in yeast and 
especially in oil seeds by overexpressing the yeast acyltransferases TAZ1 and its 
plant homologues At104.1 and At104.2 
 
Paper II: To study the CoA-activation independent acylation of fatty acids into 
waxesters and ethanolesters in A. thaliana and S. cerevisiae 
 
Paper III: To investigate long chain acyl-CoA synthetase (ACSL) isoforms and 
their expression, activity and function in Mus Musculus heart at different 
developmental stages 
 
Paper IV: Characterization of the novel glycerophosphodiester acyltransferase 
activity in S. cereviseae   34
Results and discussions 
Changes in Lipid Composition of Saccharomyces cerevisiae 
strains with Altered Glycerol-3-Phosphate Acyltransferase Gene 
Expression (paper I) 
 
If we knew what it was we were doing, it would not be called research, 
would it? - Albert Einstein 
 
In this paper, we studied the effects in yeast of deletion and overexpression of 
the two yeast GPAT genes on fatty acid content and composition. Previous results, 
indicating SCT1 is more involved in TAG biosynthesis (Zaremberg & McMaster, 
2002). These studies lead to the conclusions that GPT2 and SCT1 are the major 
ER localized GPATs in S. cerevisiae. This data also suggests that these genes have 
different functions and may be involved in different types of lipid production based 
on the needs of the organism. In this study, we will give further evidence that while 
GPT2 and SCT1 are the major ER localized GPATs in S. cerevisiae; they may 
have different functional roles. 
 
In-vitro, the GPT2 and SCT1 deletion and overexpression strains 
have different GPAT activities- In the gpt2∆ strain, GPAT activity was 
higher than in the sct1∆ strain. There is a clear decrease in GPAT activity for both 
knockout strains. For gpt2Δ and sct1Δ strains, there is a 9- and 2-fold reduction, 
respectively, as compared to WT (Fig. 1A, Paper I). In accordance to this decrease 
in the deletion strains, there is an increase in GPAT activity in crude extract from 
both yeast strains overexpressing either GPT2 or SCT1 of 3.8- and 3-fold, 
respectively, compared to the WT yeast strain (Fig. 1B).  
 
Effcts on acyl lipids are seen in gpt2Δ and sct1Δ strains when grown 
on synthetic media containing a non-fermentable carbon source to 
stationary phase - Growth conditions strongly affect the total acyl-lipid content 
(nmol FA/mg dry weight) in both knockout and WT strains, with a strong increased 
content as an effect of growth to stationary as compared to logarithmic phase, of 
growth on synthetic as compared to rich media and growth on a nonfermentable as 
compared fermentable carbon source. There is only a small difference in total acyl-
lipid accumulation in GPAT knockout as compared to WT in all growth condition, 
except at stationary stage on synthetic media supplemented with a non-fermentable 
carbon source (Fig. 2A). At stationary phase on synthetic media supplemented with 
a non-fermentable carbon source, the gpt2Δ and sct1Δ strains have approximately a 
20% and 4% decrease in total lipids compared to the wt. The different lipid classes 
are also affected in the gpt2Δ strain when grown on synthetic media supplemented 
with a non-fermentable carbon source. The gpt2Δ strain had a relative decrease in 
saturated acyl groups and a relative increase in unsaturated acyl groups (Fig. 2B). 
The stronger decrease in total acyl-lipid content in the gpt2Δ as compared to the 
sct1Δ strain correlates with the larger decrease in in-vitro GPAT activity in the  35 
crude fraction of the gpt2Δ. The total acyl lipid content per dry weight is highest at 
this growth condition. It is logical that the demand for GPAT activity also is 
highest and that a reduced GPAT activity would become noticeable. A rate-
limiting GPAT reaction would lead to an increase in the half-life of acyl-CoA 
molecules and an increase in the acyl-CoA pool. The 16:0-CoA and 18:0-CoA are 
substrates for the yeast desaturase, which would have an increased substrate 
availability, which is an temting explanaition to the enhanced desaturation seen. 
 
Deletion of GPT2 and SCT1 affect acyl composition –The acyl 
composition of  total lipids as well as lipid class composition was analyzed on S. 
cerevisiae cells grown to stationary stage on synthetic media supplemented with a 
non-fermentable carbon source. In the sct1Δ strain hardly no effect was seen on 
acyl composition of the total lipid content when compared to WT cells. The gpt2Δ 
strain on the other hand showed a puite drastic enhancment in desturation level, 
which correlates with the effect seen on total lipid content (Fig 2B and 2A). In the 
gpt2Δ deletion strain, there was 5% decrease in relative DAG content and a 4% 
increase in relative TAG content (Fig.3), which indicates that a larger amount of 
LPA produced by SCT1 is incorporated into TAG molecules than those produced 
by GPT2. This is in agreement with the findings by (Zaremberg & McMaster, 
2002) by in vivo feeding of [
14C]acetate. 
 
Overexpression of GPT2 and SCT1 affects the conten, composition and 
acyl distribution of lipids – Acyl lipid composition and content was analyzed 
in S. cerevisiae strains overexpressing either GPT2 or SCT1 behind the strong 
inducible  GAL1-promoter, grown to stationary stage on synthetic media 
supplemented with a non-fermentable carbon source. In the GPT2 and SCT1 
overexpression strains there were a 50% and 70% increase in total acyl content 
(nmol FA/g dry weight), respectively (Fig. 4). This is interesting as the SCT1 
overexpression induces a higher increase in total acyl lipid content as compared to 
GPT2, while in-vitro GPAT activity levels in the crude extract is the oposite. GPT2 
and  SCT1 overexpression also has effects on the acyl composition seen in the 
analysis of total lipids, with a quite significant reduction in unsaturation level (Fig. 
5C). Overexpression of GPT2 had a corresponding increase in 18 carbon 
molecules, while the SCT1 strain had an increase in the 16 carbon molecules (Fig. 
5B, Paper I). This increase in 16 carbon species due to SCT1 overexpression 
correlates with SCT1 in-vitro acyl preference. GPT2 does not have a fatty acyl 
preference in-vitro, so the increase in the 18 carbon molecules may be due to a 
change in SCT1 and GPT2 activities in the yeast cells. When we looked at total 
saturation versus unsaturation, we found that GPT2 and SCT1 both increased 
saturated acyl groups (Fig. 5C, Paper I). Both GPT2 and SCT1 overexpression 
increased DAG and free fatty acid (FFA) production. DAG is a lipid intermediate 
for TAG, the final step in glycerol lipid biosynthesis. Due to this increase in DAG, 
we can assume that the final steps in lipid biosynthesis now are rate limiting instead 
of the earlier one. The increase in FFA could be due to an increase in fatty acid 
turnover or breakdown of acyl-CoAs. The large increase in in-vitro total GPAT 
activity as compared to the WT would definitely cause a sink for acyl-CoA’s, 
which would argue against the hydrolysis of acyl-CoAs. However, there are some 
differences. Overexpression of GPT2 leads to a 28% increase in the FA content in   36
phospholipids as compared to wt. SCT1 increased FA content in TAG molecules 
by 68% as compared to WT (Fig 6A). The higher increase in PL, FA and DAG 
molecules due to GPT2 overexpression leads us to believe that the increase in FFA 
content is due to increased phospholipid turnover. When we looked at acyl 
composition of the lipid classes, we found even more differences. Both 
overexpression strains show decreases in 16:1 and 18:1 in PL and DAG and a 
smaller decrease in the FFA molecules. The decreases in unsaturated species of PL 
are compensated by a general increase in the saturated species. The decrease in 
incorporation into unsaturated acyl groups is compensated by an increase in 16:0 in 
both overexpression strains and an increase in 18:0 in the GPT2 overexpression 
strain. In the GPT2 overexpression strain, there is an increase in 18:0 and SCT1 
16:0. Overexpression of SCT1 increases incorporation in 16:0 TAG molecules 
(Fig.7, Paper I). From these findings, as well as those above, we conclude that in S. 
cerevisiae, strong GPAT gene overexpression will elevate de-novo FA 
biosynthesis, which will lead to an increase in acyl lipid content and a reduction in 
total unsaturation level. The large increase in in-vitro total GPAT activity as 
compared to the WT would definitely cause a sink for acyl CoA’s. The result 
indicates to us that acyl-CoA is a possible signal for FA synthesis in S. cerevisiae. 
The elevated FA production is then separately channeled into the two different 
GPAT paths. Incorporation by SCT1 causes an accumulation into TAG molecules 
while that by GPT2 does not. 
 
Use of TAZ1 for Increasing Oil Quantity in Plants (Patent I) 
The most exciting phrase to hear in science, the one that heralds new 
discoveries, is not "Eureka!" (I found it), but "That's funny..."- Isaac 
Asimov 
Yeast Tafazzin (TAZ1) is involved in the incorporation of Glycerol 3-
phosphate into Lysophosphatic acid. - In initial studies on the incorporation 
of [
14C]glycerol-3-phosphate in the presence of acyl-CoA (GPAT assay) in crude 
extraxts of a TAZ1 S. cerevisiae knockout strain as compared to WT we found a 
reduction of approximately 60%. Overexpression of the TAZ1 gene behind the 
strong inducible GAL1 promotor on a multicopy plasmid resulted in a 2.5-fold 
increase in GPAT activity in crude extracts as compared to the empty plasmid 
control (Fig.1, 2). There is strong evidence supporting the involvement of TAZ1 in 
cardiolipin remodeling and our results show a definite role in activation of GPAT, 
suggesting that there might be a bifunctionality of this enzyme. 
 
Yeast tafazzin (TAZ1) affects lipid composition in S. cerevisiae - The 
effects on lipid composition by overexpressing the TAZ1 gene was studied by 
growing a WT strain transformed with the pAN3 vector (multicopy plasmid with a 
GAL1-TAZ construct1) on synthetic media lacking uracil and harvested after 
induction with galactose for 24 and 28 hours. Inducing the TAZ1overexpression 
strain for 24 and 28 hours increased the total lipid content by 16 and 12%, 
respectively as compared to control (Fig. 3). In the neutral lipid fraction from cells 
induced for 28 hours, we found an increase of TAG compared to the empty 
plasmid strain of 62% (Table 3). We saw similar levels of TAG accumulation in  37 
cells grown for 24 hours. Interestingly, in the polar lipid fraction, the total content 
per dry weight decreased up to 34% with overexpression of TAZ1 (Table 4). The 
relative content of phospholipids was different from the empty plasmid strain as 
well. The relative content of PI and PE was decreased while PC and PS was 
increased (Table 4). These results lead to the conclusion that TAZ1 is a good 
candidate for use to increase oil quantity in oilseeds.  
 
Overexpression of A. thaliana genes At104.1 and At104.2 affect lipid 
composition in S. cerevisiae. - The effects of the TAZ1 homologues At104.1 
and At104.2 from A. thaliana has on lipid composition in S. cerevisiae was studied 
by overexpressing  the genes behind the GAL1 promoter and introduced the 
multicopy vector and an empty control vector into a WT yeast strain. Yeast cells 
were grown on synthetic media lacking uracil and harvested after induction with 
galactose for 24 hours. Total lipid content in the At104.1 and At104.2 
transformants were increased 42% and 45%, respectively, compared to the empty 
plasmid control (Table 5). As with TAZ1, overexpression of At104.1 and At104.2 
increased triacylglycerol content significantly, 79% and 92% respectively. The 
accumulation of phospholipids was slightly lowered and the FA and DAG content 
increased slightly (Table 5). In the major polar lipid classes, the most pronounced 
effect was seen with PI, where there was a decrease with overexpression of 
AT104.1 and At104.2 of 39% and 33%, respectively (Table 6). For potential use of 
these genes in lipid manipulation of TAG, we were also interested in the effect 
these genes had on fatty acid composition. The overexpression of At104.1 and 
At104.2 increased the over all oleic acid content  approximately 1.5-fold and 
decreased palmitic acid  content approximately 2-fold in S. cerevisiae compared to 
the empty plasmid control (Table 7). There was also a small increase in stearic acid 
of approximately one fold. 
 
Transgenic plants expressing A. thaliana genes At104.1 and At104, 2 
and S. cerevisiae genes TAZ1 increase relative seed oil content in A. 
thaliana. - The effect of overexpression of the yeast and A. thaliana tafazzin 
homologues on seed oil content was evaluated in A. thaliana. To do this the plant 
genes were expressed from a constitutive CaMV35S or a seed specific napin 
promoter. TAZ1 was introduced into the plant expression vector pSUN300-USP 
under the control of the seed specific USP promoter. Seed oil content was 
increased in T2 and T3 generation of A. thaliana by all three overexpressed genes. 
This confirms that A. thaliana genes At104.1 and At104.2 and S. cerevisiae genes 
TAZ1 do influence lipid accumulation. This makes them prominent candidates for 
increasing oil quality and quantity in plants through use of plant biotechnology.  
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Microsomal preparations from plant and yeast acylate free fatty 
acids without prior activation to acyl thioesters (Paper II) 
If the facts don't fit the theory, change the facts -Albert Einstein 
In this paper, we show an alternative to both wax ester and ethyl ester 
production. Acylation of free fatty acids in cells is assumed to require that the acyl 
group is first activated to a thioester in the form of either CoA or ACP derivatives 
prior to acylation. It has been reported that enzymes in subcellular fractions or in 
aqueous environment can catalyze the acylation of free fatty acids to hydroxy or 
amine groups (Boutur, Dubreucq & Galzy, 1995; Chapman & Moore, 1993; 
Friedberg & Greene, 1967; Kolattukudy, 1967; Okumura, Iwai & Tsujisaka, 1979). 
In this paper, we discovered that the membranes catalyzed efficient acylation of 
free fatty acids to both endogenous and added fatty alcohols (Banas et al., 2005).  
 
Microsomal membranes from Arabidopsis leaves and roots efficiently 
acylate free fatty acids to long chain alcohols with no activation of the 
fatty acids to thioesters prior to acylation. - It has been previously thought 
that a series of enzymatic steps led to two main wax biosynthetic pathways: the 
acyl reduction pathway and the decarbonylation pathway (Kunst & Samuels, 
2003). In this paper, we have characterized a novel biochemical reaction of wax 
production. This is a reduction pathway that utilizes reduced aldehydes or primary 
alcohols to transacylate neutral lipids to form wax esters without involvement of 
acyl-CoA. In this study, we have characterized this novel enzymatic step and 
proved that it was an enzymatically catalyzed. Microsomal membranes from 
Arabidopsis leaves and roots efficiently acylated free fatty acids to long chain 
alcohols with no activation of the fatty acids to thioesters prior to acylation. We 
went about proving this using several methods. We researched this by optimization 
of substrates, heat treatment, DTNB addition and PMSF addition. After discovery 
of this unusual wax ester production, we went about optimizing the assay with 
respect to time and substrate preferences. Wax ester synthase activity with final 
optimized conditions in a time course is shown in (Fig. 1 of Paper 2). We wanted 
to confirm that the reaction was enzymatic. The first step we took towards proving 
this was by heat treatment of microsomal membranes. We did this by boiling the 
microsomes at 90ºC for 10 minutes and then running the optimized enzymatic 
assay on these boiled microsomes. There was no wax ester production with boiled 
microsomes under our optimized conditions. Addition of 
phenylmethylsulphonylfluoride (PMSF), an inhibitor of serine proteases, somewhat 
inhibited the activity in leaf microsomes at low microsomal concentrations 
(Fig.1B). Root microsomal membrane wax ester synthesizing activity was 5.5-fold 
less than that of leaf microsomes. In order to investigate whether formation of wax 
esters required access to free SH groups, the microsomal preparations of 
Arabidopsis leaves were incubated with [
14C]18:1 and 22:1-OH in the presence of 
high amount of dithionitrobenzoic acid (DTNB), which covalently reacts with free 
SH groups of CoA or ACP. The formation of wax esters was not affected by 
DTNB (Fig.2, lane A and B of Paper 2). No detectable amounts of other formed 
radioactive lipids were seen in the presence of DTNB. Addition of CoA and ATP 
to incubations of microsomes with [
14C]18:1 in presence or absence of docosa-13- 39 
enol resulted in extensive incorporation of fatty acids into polar lipids (Fig.2, lane 
B and D of paper 2), demonstrating that the microsomal membranes contained 
active acyl-CoA dependent acyltransferases. Incubation with CoA and ATP in the 
presence of surplus molar concentrations of DTNB in relation to the CoA totally 
inhibited the transfer to polar lipids but did not affect the formation of wax esters 
(Fig. 2, lane C and E of paper 1 of paper 2). These results clearly showed that the 
formation of wax esters did not require activation of the free fatty acid to 
thioesters. 
  
In Arabidopsis leaves, fatty acids specificity of the reaction showed 
that long chain (C18-C24) unsaturated fatty alcohols were preferred. - 
Major monomers of cutins in Arabidopsis leaf are omega-hydroxylated fatty acids 
and long chain dicarboxylic acids (Bonaventure et al., 2004). We  tested omega-
hydroxylated fatty acids and long chain diols as a substrate for the acylation of free 
fatty acids in leaf microsomal membranes as well as primary fatty alcohols and 
[
14C]oleic acid. We found that saturated alcohols were acylated with decreasing 
rates with increasing chain length (Fig. 3B of paper 2). Unsaturated alcohols were 
preferred substrates and were acylated with about the same rate, regardless of 
unsaturation and chain lengths ranging from 18 to 24 carbons (Fig. 3B of paper 2). 
We also looked at docosa-13-enol as an acyl acceptor in the presence of several 
fatty acyls. What we found there was a preference for the unsaturated fatty acyls 
18:1, 18:2, and 18:3, but ricinoleic acid (12-hydroxy.octadec-9-enoic acid) and 
saturate fatty acyls were poorly utilized (Fig. 3A of Paper 2). Omega C18 diols 
were rapidly acylated by free fatty acids in Arabidopsis leaf membranes and the 
enzyme(s) appeared to prefer diols with one esterified fatty acid.  
 
Microsomes from yeast and Arabidopsis roots and leaves efficiently 
synthesized ethyl esters from ethanol and free fatty acids without 
prior activation of the fatty acid to a thioester. - While optimizing the 
assay, we tried an alternate method of addition of substrates. Instead of adding 
them in benzene to freeze dried microsomes we used ethanol to add substrates to 
the microsomal membranes. At low membrane concentration, the formation of wax 
esters was approximately half that of the benzene method and high concentrations 
of the membrane strongly inhibited the reaction (Fig. 1B, Fig. 4A of paper 2). 
What was a surprising result from this experiment was a significant formation of 
radio labeled ethyl esters that increase with an increase in membrane 
concentrations. This production of radiolabeled ethyl esters was shown in both root 
and leaf microsomes. However, formation of the radiolabeled ethyl ester in A. 
thaliana roots was about half of that produced in the leaves. We further 
characterized this reaction as described above and found that boiling the 
microsomes at 90ºC for 10 minutes completely abolished this activity. Also, the 
addition of DTNB had no effect on this activity. Deletion of fatty alcohols from the 
assay led to only slightly less ethyl ester formation (Fig.4A). The differences in 
relative activity of the ethyl ester and wax ester formation in leaf and root 
membranes, the non-competitive nature and the different kinetics of the two 
acylation reactions strongly suggest that they are carried out by separate enzymes. 
We also looked at ethyl ester and wax ester production in Saccharomyces 
cerevisiae. We found no wax ester production in S. cerevisiae with either the   40
ethanol or the benzene method. However, we found that with the addition of 
substrates with ethanol there was efficient synthesis of ethyl esters in the 
membranes. We also tested this in the addition of DTNB and heat treatment. As 
with the A. thaliana microsomes, there was little effect from the addition of DTNB 
and heat treatment completely abolished the activity.  
 
Herbicide treatment with alloxydim in membrane preparations of 
root tips from wheat had greatly increased phospholipase activity as 
well as increasing wax ester and ethyl ester formation from free fatty 
acids. - Root extracts from wheat treated with alloxydim, a grass herbicide, were 
shown to have increased phospholipase activity as well as increased capacity to 
synthesize ethyl esters (Banas, A. and Banas, W., unpublished observation). 
Addition of substrates in ethanol in microsomal fractions of root tips from 
alloxydim treated seedlings had over 20 times higher specific phospholipase A2 
activity as well as 7-fold higher ethyl ester and 5-fold higher wax ester synthesis 
from free fatty acids than membranes from untreated seedlings (Fig 5). This 
demonstrates that enzymes both producing and acylating free fatty acids are 
strongly activated or induced under certain physiological conditions. Treatment 
with alloxydim stops root tip growth and the root tip goes through physiological 
changes that roughen its texture. The increases in enzyme activities with alloxydim 
could possibly have a connection to induced suberin synthesis in the root tips. 
These results combined with the results above suggest a possible involvement of 
these enzymes in cutin and suberin synthesis. It was found that the lipase inhibitor 
dehydrolipstatin was an very efficient inhibitor of both wax ester and ethyl ester 
formation in microsomal membranes from Arabidopsis but had less effect on the 
formation of ethyl esters in membranes from yeast. 
 
 
Ontogeny of mRNA expression and activity of long-chain acyl-
CoA synthetase (ACSL) isoforms in Mus musculus heart. 
(Paper III) 
 
No, no, you're not thinking; you're just being logical. - Niels Bohr 
 
In this study, we investigated the ACSL isoforms, their expression and their 
activity in Mus Musculus heart at different developmental stages. The story of the 
ACSL family in developmental stages is a very complicated one. What is clear is 
that previous data and ours clearly suggest that there are different metabolic 
functions for each of these isoforms. We know that understanding these 
mechanisms is not only important for understanding fetal and neonate development 
but for understanding many adult cardiac diseases as well. It is well understood 
that in many cases of hypertrophy and heart failure, the heart switches back to what 
is referred to as “fetal energy metabolism” (Calvani, Reda & Arrigoni-Martelli, 
2000; van Bilsen et al., 2004). Understanding how the genes are regulated may 
give us important markers as indicators for heart disease. Truly understanding 
these heart metabolic functions will require much more research.  41 
 
ACSL1 is the major ACSL isoform involved in fatty acid oxidation - 
Due to past data that shows an increase in fatty acid oxidation along with an up-
regulation of genes involved in this process, we expected to see at least one ACSL 
isoform to be up-regulated as well. We looked at total ACSL activity in heart at 
different developmental stages. We found very low ACSL activity at embryonic 
day 16 (1.3 nmol/min/mg). In contrast, on postnatal day 1, ACSL activity increased 
14-fold to 18.9 nmol/min/mg. ACSL activity remained unchanged through 
postnatal day 25. In the adult mouse heart, ACSL activity is 6.6-fold higher (124.7 
nmol/min/mg) than that of the neonate (Fig. 1, Paper III). The only isoform whose 
mRNA transcript level increased after birth was ACSL1 (Fig. 2A, Paper III). 
ACSL1 message level was 2.5-fold higher at postnatal day 1, compared to 
embryonic day 16. The amount of ACSL1 mRNA remained stable throughout the 
neonatal period, but was 1.6-fold higher in the adult as compared to day 25. This 
data suggest that ACSL1 is the isoform contributing activated long-chain fatty 
acids for oxidation in the heart.   
 
ACSL3 and ACSL6 may not play a large role in postnatal ACSL 
activity - We wanted to look at which isoforms were responsible for the majority 
of heart ACSL activity at different developmental stages. To separate out the 
isoforms, we used known inhibitors triacsin C and troglitazone. Incubation of heart 
total membrane with 10 μM triacsin C inhibited ACSL activity 87 - 97% at all 
developmental time points (Fig. 3, Paper III). Because triacsin C only inhibits 
ACSL 1, 3 and 4, this data suggests that ACSL5 and ACSL6 do not contribute 
significantly to heart ACSL activity. ACSL4 is the only isoform inhibited by 
troglitazone.  
Treatment of heart membranes with 50μM troglitazone did not inhibit ACSL 
activity. These data strongly suggest that ACSL4 does not contribute to the total 
ACSL activity measured in the heart. We wanted to look at this further. The 
abundance of ACSL3, ACSL6 mRNAs was inverse to that observed for ACSL1. 
The ACSL3:β-actin ratios were highest at embryonic day 16, and were 1.8-fold 
lower after birth (Fig. 2 B, Paper III). ACSL3 mRNA levels at postnatal days 1 and 
7 are 75- and 13-fold higher, respectively, than in the adult. Due to the significant 
amounts of ACSL3 transcripts present at postnatal day 1, we wanted to assess the 
contribution of the ACSL3 isoform to total ACSL activity. ACSL3 activity assayed 
with [
14C]palmitate is inhibited by high concentrations of arachidonate (Van Horn 
et al., 2005). In heart total membrane, we found that ACSL activity at embryonic 
day 16 was inhibited up to 32 % by arachidonate when compared to hearts 
collected on day 1 or in the adult (Fig. 5, Paper III). Although arachidonic acid can 
also compete ACSL4 activity measured with palmitate (Van Horn, et al., 2005), 
our data using troglitazone (Fig. 4, Paper III) strongly suggests that ACSL4 activity 
is not significant in the embryonic heart. This data combined with previous reports 
allows us to conclude that ACSL3 and ACL6 are not major contributors to 
postnatal ACSL activity.   
 
ACSL3 and ACSL4 need post-transcriptional modification in order 
for activation to occur - During this study, we saw some unusual changes. We 
noticed an in concordance of mRNA levels and total ACSL activity in the heart. At   42
embryonic day sixteen, ACSL 3 and ACSL4 have a 137- and 5-fold increase in 
mRNA compared to the adult stage. There is a 75-fold increase in mRNA level at 
postnatal day one for ACSL3 as compared to the adult stage, and comparable 
levels to the adult stage for ACSL4 (Fig.2, B, C, Paper III). The largest decreases 
in total activity were at embryonic day sixteen, postnatal day eighteen and the adult 
stages. There was a 96.8%, 93.2% and 92.3% decrease, respectively, in total 
activity in the presence of DMSO. However, in embryonic day 16 through 
postnatal day 7, there was a 16% to 18% decrease in total ACSL activity as 
compared to the adult (Fig.3, Paper III). This data indicates that a small amount of 
total ACSL activity in the embryonic and early postnatal stages may be due to 
ACSL3 and ACSL4. There is a large discrepancy between total ACSL activity and 
the transcript levels of ACSL3 and ACSL4. Our data suggests that the ACSL3 and 
ACSL4 need post transcriptional modification in order for activation to occur. We 
understand that there are many ontological changes occurring between the 
developmental stages of Mus musculus heart, especially between the late 
embryonic and early postnatal stages. This activation of ACSL enzymes may be 
due to changes in substrate availability after birth and the high level of transcript 
that occurs before birth may actually be in preparation for events that occur in the 
postnatal stages rather than the embryonic ones.   
 
Glycerophosphodiester Acyltransferase; A New Class of 
Acylation Enzymnes in Lipid Biosynthesis (Paper IV) 
Things should be made as simple as possible, but not any simpler. 
–Albert Einstein 
 
Previously it was thought that the synthesis of Phosphatidylcholine occurred 
through two mechanism; through the reduction of CDP-choline (CDP-Cho) or by 
methylation of phosphatidylethanolamine (PE) (Dowd, Bier & Patton-Vogt, 2001; 
Fernandez-Murray & McMaster, 2005). In this study, we have identified two novel 
acyltransferase activities in eukaryotic cell membranes that carry out acylation of 
the two glycerophosphodiesters GPC and GPE. These reactions are called 
glycerophosphocholine acyltransferase (GPCAT) and 
glycerophosphoethanolamine acyltransferase (GPEAT). These enzymes utilize 
Glycerophosphocholine (GPC) and Glycerophosphoethanolamine (GPE) as acyl-
accepters and acyl-CoA as acyl donors to synthesize lysophospholipids. These new 
reactions combined with the known LPCAT and LPEAT activities create a novel 
pathway for recycling glycerophosphodiesters into phospholipids. This set of 
reactions is extremely energy efficient compared to the previously described 
glycerophosphodiester pathway by Patton-Vogt et al 2006 (Patton-Vogt, 2006).  
 
Saccharomyces cerevisiae membranes catalyzes the acylation of 
glycerophosphocholine and glycerophosphoethanolamine-  In the early 
1950’s, Dawson et al. and others identified GPC and GPE as metabolites in several 
mammalian tissues and considered them as being metabolites in the main pathway 
for lipid biosynthesis. Radioactive phosphate feeding studies, however, strongly 
indicated them as rather being catabolic products of phospholipid deacylation, 
which has been proven more lately  (Fernandez-Murray & McMaster, 2005;  43 
Zaccheo, et al., 2004). This theory is strongly supported by the fact that deletion of 
NTE1 gene in Saccharomyces cerevisiae leds to abrogation of GPC accumulation. 
It is well understood that S. cerevisiae, can degrade GPI and GPC take up in media 
sources (Almaguer et al., 2003; Fisher et al., 2005; Patton, Pessoa-Brandao & 
Henry, 1995) as well as GPC generated intracellularly (Fernandez-Murray & 
McMaster, 2005). To test if yeast utilizes GPC in addition to G3P and DHAP as an 
acceptor for acylation, an in vitro assay for GPAT activity according to Tillman 
and Bell (1986) with minor modifications was used for assaying GPAT activity and 
with an exchange of the [
14C]G3P for [
14C]GPC to assay for GPC acylation. The 
TLC image of radioactive lipids extracted from the incubated yeast extracts show 
apart from the starting point with minor contamination of water soluble 
14C-
labelled substrate, a minor background incorporation of radioactivity into lipids in 
the G3P and GPC minus acyl-CoA lane (Figure 1A). However, in the presence of 
16:0-CoA or 18:1-CoA there was significant synthesis of both 
14C-labelled LPA 
and PA when [
14C]G3P was added as acyl-acceptor and of 
14C-labelled LPC as 
well as of PC when [
14C] GPC was added (Figure 1A). These data clearly show 
that the crude yeast extract has an enzymatic activity capable of acylating the GPC 
molecule and that LPC is readily available for a second acylation by the well-
known LPCAT enzyme. We further tested all glycerophosphodiesters for acylation 
activity in yeast membranes and found apart from GPC that also GPE was utilized 
for acylation. The new acyltransferase activities, the glycerophosphocholine 
acyltransferase (GPCAT) with a Vmax in microsomes of 8.7 nmol/min/mg (Fig. 4) 
and glycerophosphoethanolamine acyltransferase (GPEAT) whose activity is only 
a small percent of the GPCAT activity (Fig 1A and 1C). Comparing the GPCAT 
activity to other acylation activities in S. cerevisiae, we determined GPCAT to be 
approximately one fourth of that of the relativley active GPAT activity indicating 
that GPCAT is not a minor activity in this organism. The GPCAT activities 
showed some week acyl prefences but the further acylation of both LPC and LPE 
by the LPCAT and LPEAT activities in the yeast extracts were however more 
strongly favoured by unsaturated acyl-CoAs. (Fig. 1A and C). 
 
 
In Saccharomyces cerevisiae extracts, GPC acylation is not catalyzed 
by GPT2 or SCT1- To test wether any of the two yeast GPATs, GPT2 or SCT1, 
is responsible for the acylation of GPC we compared GPCAT and GPAT activities 
in both crude extracts from WT yeast with knockout and overexpression strains. 
The deletion strains gpt2∆ and sct1∆ had the same GPCAT activity as WT but 
strongly reduced GPAT activies (Fig. 3A). Similar results were obtained with the 
overexpression strains of GPT2 and SCT1 with no effects on GPCAT activity as 
compared to WT but strong effects on GPAT activity (Fig. 3B). We further 
characterized the GPCAT activity in microsomal preparations of WT yeast cells 
and compared it to the well-known GPAT activity. The GPCAT activity was linear 
in respect to added microsomal proteins up to 25 mg at 10 minutes incubations 
while the GPAT was fairly linear linear to 20 mg at 5 minutes incubations. The 
GPCAT enzyme can utilize a broad spectrum of pH optimums from 6.5 to 8.5, but 
activity drops significantly if the pH drops below 6.5 (Fig. 4C). When testing the 
basic assay conditions, we found that 2 mg/ml of BSA increased the GPCAT 
activity by approximately 20% while addition of 2 mM of MgCl2
 inhibited activity   44
by 50%. The effect of divalent ions was further tested with the addition of 2 mM of 
Ca
2+, Mn
2+ and Zn 
2+. Ca
2+ showed similar inhibition to Mg
2+ while Zn
2+ and Mn
2+ 
completely inhibited the GPCAT activity. Addition of EDTA showed no 
significant difference whereas the strong divalent ion chelator phenantroline 
completely inhibited the activity. The sulfhydryl reagent N-ethylmalemid (NEM) 
also strongly inhibits the GPCAT activity (Table II). We looked at the effect of 
heat shock on the GPAT and GPCAT activities. Saccharomyces cerevisiae 
membranes were incubated at 50C for 30minutes. This completely inhibited the 
GPAT activity while it enhanced GPCAT activity by 30% (Table III). This, 
combined with old data that shows an increase of GPC production with increased 
growth temperatures (Dowd, Bier & Patton-Vogt, 2001), leads us to conclude 
GPCAT recycling activity in Saccharomyces cerevisiae membranes may be 
activated by stress elements such as heat. 
 
GPCAT activity in higher eukaryotes - We further tested if the GPCAT 
activity is present in tissue extracts of higher eukaryotes. We tested three different 
mammalian extracts: the Homo sapien renal epithelial cell line 293T, Mus 
musculus liver and Rat Ratus developing brains. We found no evidence of GPCAT 
activity in these tissues (data not shown). This does not rule out the possible 
existence of GPCAT in mammalian species but rather may point that this enzyme 
has a very specific function and that these activities might be difficult to measure in 
vitro. A microsomal preparation from developing Ulmas glabra (Elm) seed was 
tested. Plants with high oil content seeds are extremely active in lipid synthesizing 
enzymes. In this tissue, we found GPCAT activity, which was about 50% of that of 
the GPAT activity and thus of similar rate as in yeast extracts (Fig. 2). Further 
more, incorporation of [
3H-choline]GPC added to the growth media under low 
phosphate conditions to a pct1Δ and a pct1Δgde1Δ knockout strain suggests that 
the GPCAT pathway for PC biosynthesis is functional in vivo. 
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End 
 
I have no special talent. I am only passionately curious. 
 -Albert Einstein 
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“Life is, and has always been a struggle. The fishing pole bends heavier for 
some than others, and nobody has yet to figure out why – just as you never 
know, when you make a cast, if what attacks your fly is a finger-size baby 
snapper or a tiger shark that can turn you into bait. Still we struggle with the 
rod just the same. Life to me is like a fish on the line. When it is there, you feel 
it. You fight it. You gain the line. You lose the line. But if that line suddenly 
snaps, or the pole breaks, or a thousand other problems occur that fisherman 
use as excuses when the tension is gone, you feel it even more.”                                                                           
- Jimmy Buffet (Buffet, 2004).   46
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